Stem Point Capital LP Aadi Bioscience, Inc. Transaction History
Stem Point Capital LP
- $499 Billion
- Q3 2025
A detailed history of Stem Point Capital LP transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 424,082 shares of AADI stock, worth $725,180. This represents 0.16% of its overall portfolio holdings.
Number of Shares
424,082Holding current value
$725,180% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding AADI
# of Institutions
44Shares Held
29.4MCall Options Held
0Put Options Held
0-
Qvt Financial LP New York, NY4.62MShares$7.89 Million0.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.17MShares$7.12 Million0.24% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.7MShares$6.33 Million0.19% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA3.41MShares$5.83 Million10.98% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.85MShares$4.87 Million0.07% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $35.9M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...